Eastman Chemical (EMN) Receivables (2009 - 2026)

Eastman Chemical (EMN) has reported Receivables for 18 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 1.87% year-over-year to $1.4 billion; the trailing twelve-month figure through Jun 2026 stood at $1.4 billion (up 1.87% YoY), and the FY2025 full-year result was $999.0 million, down 14.76% from the prior year.
• Receivables climbed to $1.4 billion in Q2 2026 per EMN's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Receivables topped out at $1.6 billion in Q1 2022 and bottomed at $999.0 million in Q4 2025.
• Historically, Receivables has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Receivables retreated 27.92% in 2023, then rose 15.93% in 2024.
• Over 5 years, Receivables stood at $1.3 billion in 2022, then decreased by 9.63% to $1.2 billion in 2023, then advanced by 1.56% to $1.2 billion in 2024, then fell by 14.76% to $999.0 million in 2025, then surged by 36.64% to $1.4 billion in 2026.
• According to Business Quant data, Receivables over the past three periods registered $1.4 billion, $1.2 billion, and $999.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.